PURPOSE: To report the frequency of caval occlusion after Vena Tech-LGM fil
ter placement and identify related factors and their potential clinical sig
nificance.
MATERIALS AND METHODS: The filter was inserted into 243 patients, 142 of wh
om met inclusion criteria for this prospective study. Follow-up examination
s performed every 2 years included clinical evaluation, plain frontal radio
graphy of the abdomen, duplex scanning of the inferior vena cava (IVC), and
/or phlebocavography,
RESULTS: A progressive decrease in IVC patency was observed, reaching 66.8%
at 9 years of follow-up. Complete caval occlusion occurred in 28 patients
and was significantly (P < 10(-6)) associated with retraction in 24 cases.
Caval occlusion was not related to age, sex, pulmonary embolism (PE), deep
venous thrombosis level, underlying conditions predisposing to a thromboemb
olic disease before filter insertion, the level of filter placement, use of
anticoagulant therapy, and death during follow-up. PE with anticoagulation
failure was a predictive factor (P = .016) of subsequent filter occlusion
during follow-up as compared to all other clinical indications for filter p
lacement. Filter patency at 9 years of follow-up was 35.2% in the PE group
with anticoagulation failure and 80% for other patients (odds ratio, 2.5; 9
5% confidence interval 1.16 - 5.4).
CONCLUSION: PE with anticoagulation failure was the only factor predictive
of subsequent caval occlusion observed in patients after Vena Tech-LGM filt
er placement. Caval occlusion was also related to Vena Tech-LGM filter retr
action, which usually occurred at the time of occlusion.